Single Ascending-dose Study of the Efficacy, Safety, Tolerability, and Pharmacokinetics of REGN1908-1909 in Allergic, Adult Participants
Clinical trial NCT02127801 · COMPLETED
Trial details
- NCT number
- NCT02127801
- Sponsor
- Regeneron Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-10-31
- Primary completion
- 2015-12-31
- Enrollment
- 74
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.